menu
    • menu

    Company profile for Hyundai Bioscience

    NEW Drugs in Dev: 2
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HYUNDAI BIOSCIENCE’s research & innovation center has continuously produced globally recognized research results with the commercialization of LDH based on Organic-Inorganic Hybrid technology. Based on the long accumulated research know-how, HYUNDAI BIOSCIENCE is the only company commercialized new DDS (Drug Delivery System) using LDH Platform Technology. Through application of LDH Platform Technology, our research & innova...
    HYUNDAI BIOSCIENCE’s research & innovation center has continuously produced globally recognized research results with the commercialization of LDH based on Organic-Inorganic Hybrid technology. Based on the long accumulated research know-how, HYUNDAI BIOSCIENCE is the only company commercialized new DDS (Drug Delivery System) using LDH Platform Technology. Through application of LDH Platform Technology, our research & innovation center has developed a variety of DDS commercialization techniques such as oral, dermal and injection. We hold various patents for these techniques and materials both domestically and internationally.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hyundai Biosciencekorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    3rd floor Academic Cooperation Building Ehwa Women’s University 150 North-Ah...
    Telephone
    Telephone
    +82 70 7008 0114
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.hyundaibioscience.com/kor/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hyundai Bioscience USA Offers Free Drug Supply to WHO Trials
    Hyundai Bioscience USA Offers Free Drug Supply to WHO Trials

    11 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hyundai-bioscience-usa-offers-free-drug-supply-and-funding-for-clinical-trials-to-who-302797761.html

    PR NEWSWIRE
    11 Jun 2026
    Share Share
    Hyundai Bioscience Discloses XAFTY IC50 Data for Ebola
    Hyundai Bioscience Discloses XAFTY IC50 Data for Ebola

    21 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hyundai-bioscience-discloses-xaftys-ic50-data-for-ebolasecured-scientific-evidence-for-immediate-treatment-302778319.html

    PR NEWSWIRE
    21 May 2026
    Share Share
    Hyundai Bioscience Can Supply Antiviral for Ebola or Hantavirus
    Hyundai Bioscience Can Supply Antiviral for Ebola or Hantavirus

    20 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7449880

    FIRSTWORD PHARMA
    20 May 2026
    Share Share
    Penetrium™ Shows Promise Against Cold & Metastatic Tumors
    Penetrium™ Shows Promise Against Cold & Metastatic Tumors

    07 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/penetrium-breaks-oncology-barriers-the-solution-to-cold-tumors-and-metastatic-cancer-unveiled-at-aacr-2025-302449437.html

    PR NEWSWIRE
    07 May 2025
    Share Share
    Hyundai Bio & DNDi sign MoU for joint development of Xafty-based dengue
    Hyundai Bio & DNDi sign MoU for joint development of Xafty-based dengue

    06 Feb 2025

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/25/25539/hyundai-bio-and-dndi-sign-mou-for-joint-development-of-xafty-based-dengue-treatment.html

    BIOSPECTRUM
    06 Feb 2025
    Share Share
    Hyundai Bioscience Plans Phase 3 Trial For High-Risk COVID-19 Patients
    Hyundai Bioscience Plans Phase 3 Trial For High-Risk COVID-19 Patients

    28 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hyundai-bioscience-to-conduct-phase-3-clinical-trial-for-high-risk-group-of-covid-19-patients-with-the-goal-of-emergency-use-authorization-302232773.html

    PR NEWSWIRE
    28 Aug 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search